1-hexadecyl-2-acetyl-glycero-3-phosphocholine and lanosterol

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with lanosterol in 1 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (lanosterol)	Trials (lanosterol)	Recent Studies (post-2010) (lanosterol)
9,156	187	552	1,010	8	335

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hong, J; Im, KS; Jung, JH; Kim, YR; Lee, IS; Shin, BA; Sim, CJ; Sung, CK	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and lanosterol

Article	Year
Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis. Journal of natural products, 1999, Volume: 62, Issue:11 Topics: Animals; Anticholesteremic Agents; Cell Line; Cells, Cultured; Cholesterol; Depression, Chemical; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lanosterol; Liver; Lovastatin; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Platelet Activating Factor; Porifera	1999

Article

Year

Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis.

Journal of natural products, 1999, Volume: 62, Issue:11

Topics: Animals; Anticholesteremic Agents; Cell Line; Cells, Cultured; Cholesterol; Depression, Chemical; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lanosterol; Liver; Lovastatin; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Platelet Activating Factor; Porifera

1999